Program Schedule

77
When Should We Use Combination Therapy?

Friday, October 10, 2014: 7:00 AM-8:15 AM
Room: The Pennsylvania Convention Center: 120-ABC
Co-organized with the Society of Infectious Diseases Pharmacists

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the potential clinical benefit and harm linked to combination antimicrobial therapy
  • interpret the literature examining the impact of combination antimicrobial therapy
  • discuss the rationale and clinical experience of the use of combination therapy against multidrug-resistant Gram-positive and Gram-negative pathogens

Target Audience: Researchers, Pharmacists, Nurses, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Health care workers, Fellows, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Adult ID

Meet-the-professors:  Robert Bonomo, MD, Louis Stokes Cleveland Veterans Affairs Medical Center and Michael Rybak, PharmD, MPH, Detroit Med. Ctr.

Presentations:
7:30 AM
569
Gram-positive Bacteria
Michael Rybak, PharmD, MPH

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-14-113-L01-P

Disclosures:

R. Bonomo, None

M. Rybak, Cubist: Consultant, Grant Investigator and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium
Forest: Consultant, Grant Investigator and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium
Theravance: Consultant, Grant Investigator and Speaker's Bureau, Consulting fee, Research grant and Speaker honorarium
Durata: Consultant, Consulting fee
NIH: Investigator, Research grant

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek